Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 4/20 | 0.97 |
| ▸ | MAPT | P10636 | 3/20 | 0.97 |
| ▸ | PDE4A | P27815 | 2/20 | 0.97 |
| ▸ | SNCA | P37840 | 2/20 | 0.97 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.97 |
| ▸ | PGR | P06401 | 1/20 | 0.97 |
| ▸ | HTR1A | P08908 | 1/20 | 0.97 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.97 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.97 |
| ▸ | DRD3 | P35462 | 1/20 | 0.97 |
| ▸ | MAOB | P27338 | 2/20 | 0.66 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | DHODH | Q02127 | 2/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 8/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Menaquinone-2 SCHEMBL29355593 | 1.00 | PTGS1 (0.97) | PTGS1MAPTPDE4ASNCAPDE3A | |
| Menaquinone-2 SCHEMBL30606255 | 1.00 | PTGS1 (0.97) | PTGS1MAPTPDE4ASNCAPDE3A | |
| Menaquinone-2 SCHEMBL571905 | 1.00 | PTGS1 (0.97) | PTGS1MAPTPDE4ASNCAPDE3A | |
| SCHEMBL571907 | 0.99 | PTGS1 (1.00) | PTGS1MAPTPDE4ASNCAPDE3A | |
| Menatetrenone SCHEMBL571912 | 0.99 | PTGS1 (1.00) | PTGS1MAPTPDE4ASNCAPDE3A | |
| SCHEMBL8709976 | 0.99 | PTGS1 (1.00) | PTGS1MAPTPDE4ASNCAPDE3A | |
| Menaquinone 7 SCHEMBL436068 | 0.99 | PTGS1 (1.00) | PTGS1MAPTPDE4ASNCAPDE3A | |
| Menaquinone 6 SCHEMBL244452 | 0.99 | PTGS1 (1.00) | PTGS1MAPTPDE4ASNCAPDE3A | |
| SCHEMBL14164356 | 0.99 | PTGS1 (1.00) | PTGS1MAPTPDE4ASNCAPDE3A | |
| Menatetrenone SCHEMBL8703544 | 0.99 | PTGS1 (1.00) | PTGS1MAPTPDE4ASNCAPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240082198-A1 | STABILIZED ALKYL NITRITE COMPOSITIONS | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. (US) | 2024-03-14 | — | — | US | disclosed |
| US-10307445-B2 | Bacterial strains having an outstanding ability to produce menaquinone | DuPont Nutrition BioScience ApS (DK) | 2019-06-04 | — | — | US | disclosed |
| US-20180183102-A1 | LITHIUM AIR BATTERY INCLUDING QUINONE-BASED LIQUID CATALYST INDUCING DISCHARGE IN SOLUTION | HYUNDAI MOTOR COMPANY (KR) | 2018-06-28 | — | — | US | disclosed |
| US-20180066326-A1 | SOLID FORMS OF MENAQUINOLS | GNOSIS S.P.A. (IT) | 2018-03-08 | — | — | US | disclosed |
| EP-2419506-B1 | BACTERIAL STRAINS HAVING AN OUTSTANDING ABILITY TO PRODUCE MENAQUINONE | DUPONT NUTRITION BIOSCI APS (DK) | 2017-10-25 | — | — | EP | disclosed |
| US-20170056339-A1 | FORMULATION OF FAT-SOLUBLE VITAMIN | BASF SE (DE) | 2017-03-02 | — | — | US | disclosed |
| US-20170056339-A1 | FORMULATION OF FAT-SOLUBLE VITAMIN | BASF SE (DE) | 2017-03-02 | — | — | US | disclosed |
| CN-102753678-B | Strain having excellent ability to produce menaquinone | 杜邦营养生物科学有限公司 | 2016-10-26 | — | — | CN | disclosed |
| US-20160250160-A1 | COMPOSITIONS FOR TREATING OR PREVENTING CARDIOVASCULAR DISEASE | NATTOPHARMA ASA (NO) | 2016-09-01 | — | — | US | disclosed |
| CN-104721174-B | The new application of multiprenylmenaquinone compounds | 南通大学 | 2016-08-24 | — | — | CN | disclosed |
| US-5608092-A | INTERMEDIATES FOR VITAMIN K DERIVATIVES | EISAI CHEMICAL CO., LTD. (JP) | 1997-03-04 | — | — | US | disclosed |
| US-5476955-A | Process for the preparation of a quinone derivative | EISAI CHEMICAL CO., LTD. (JP) | 1995-12-19 | — | — | US | disclosed |
| US-5412124-A | Preparation process of naphthoquinone derivative and intermediate for the preparation thereof | EISAI CHEMICAL CO., LTD. (JP) | 1995-05-02 | — | — | US | disclosed |
| EP-0636598-A1 | Preparation process of naphthoquinone derivatives and intermediates for the preparation thereof | EISAI CHEMICAL CO., LTD. (JP) | 1995-02-01 | — | — | EP | disclosed |
| EP-0613877-A1 | Preparation process of quinone derivative and intermediate for the preparation thereof | EISAI CHEMICAL CO., LTD. (JP) | 1994-09-07 | — | — | EP | disclosed |
| EP-0172427-B1 | PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER | Shin-Etsu Chemical Co., Ltd. (JP) | 1989-07-05 | — | — | EP | disclosed |
| US-4818441-A | MEMBRANE STABILIZERS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-04-04 | — | — | US | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160250160-A1 | COMPOSITIONS FOR TREATING OR PREVENTING CARDIOVASCULAR DISEASE | PROC, MYLK, MYLK2 | PTGS1 595/4885MAPT 3422/4885PDE4A 2874/4885 |
| US-20180066326-A1 | SOLID FORMS OF MENAQUINOLS | VKORC1L1, PROC, VKORC1 | PTGS1 1358/4885MAPT 3291/4885PDE4A 2694/4885 |
| US-10307445-B2 | Bacterial strains having an outstanding ability to produce menaquinone | COASY, FDPS, BLVRB | PTGS1 1757/4885MAPT 3716/4885PDE4A 1237/4885 |
| US-20240082198-A1 | STABILIZED ALKYL NITRITE COMPOSITIONS | NDUFV2, NOS2, NDUFS3 | PTGS1 524/4885MAPT 1332/4885PDE4A 1109/4885 |
| US-20170056339-A1 | FORMULATION OF FAT-SOLUBLE VITAMIN | PROC, VKORC1, VKORC1L1 | PTGS1 632/4885MAPT 3260/4885PDE4A 976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.